Kaneko T, Iba Y, Zenita K, Shigeta K, Nakano K, Itoh W, Kurosawa Y, Kannagi R, Yasukawa K
Biotechnology Research Laboratory, Tosoh Corporation, Kanagawa.
J Biochem. 1993 Jan;113(1):114-7. doi: 10.1093/oxfordjournals.jbchem.a123993.
Stage-specific embryonic antigen-1 (SSEA-1) is a well-known carbohydrate antigen that is specifically expressed on the surface of cancer cells as well as embryonic cells. In this study, starting with a previously established hybridoma producing a monoclonal antibody (named H18A) to Lewis Y antigen, which is closely related to SSEA-1, we cloned genomic DNA encoding active variable regions both of heavy and light chains of the antibody. Sequence analysis showed that VH and V kappa genes of H18A were in the VH 7183 family and V kappa C1 family, respectively. A transfected cell line named HC-H18A-7 expressing a recombinant chimeric H18A composed of mouse-derived antigen-binding variable regions and human-derived constant regions was established. The chimeric H18A was purified to homogeneity and shown to bind purified Lewis Y antigen with the same dose-response curve as the original H18A. The chimeric H18A looks more promising for clinical application than the original mouse-derived H18A because its antigenicity is expected to be reduced.
阶段特异性胚胎抗原-1(SSEA-1)是一种著名的碳水化合物抗原,在癌细胞以及胚胎细胞表面特异性表达。在本研究中,我们从先前建立的产生与SSEA-1密切相关的Lewis Y抗原单克隆抗体(命名为H18A)的杂交瘤入手,克隆了编码该抗体重链和轻链活性可变区的基因组DNA。序列分析表明,H18A的VH和Vκ基因分别位于VH 7183家族和Vκ C1家族。建立了一个转染细胞系,命名为HC-H18A-7,其表达由小鼠来源的抗原结合可变区和人来源的恒定区组成的重组嵌合H18A。嵌合H18A被纯化至同质,并显示与纯化的Lewis Y抗原结合,其剂量反应曲线与原始H18A相同。嵌合H18A在临床应用上比原始的小鼠来源的H18A更具前景,因为预计其抗原性会降低。